Cite
APA Citation
Morita, A., Takahashi, H., Ozawa, K., Imafuku, S., Takekuni, N., Takahashi, K., Matsuyama, T., Okubo, Y., Zhao, Y., Kitamura, S., Takei, K., Yokoyama, M., Hayashi, N., & Terui, T. (2021). long‐term analysis of adalimumab in Japanese patients with moderate to severe hidradenitis suppurativa: Open‐label phase 3 results. Journal of dermatology, 48(1), 3–13. http://access.bl.uk/ark:/81055/vdc_100118923980.0x000041